ImpediMed Limited (ASX:IPD)
0.0190
-0.0020 (-9.52%)
Feb 5, 2026, 4:10 PM AEST
ImpediMed Market Cap
ImpediMed has a market cap or net worth of 38.74 million as of February 5, 2026. Its market cap has decreased by -65.83% in one year.
Market Cap
38.74M
Enterprise Value
31.04M
Revenue
12.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since October 24, 2007, ImpediMed's market cap has decreased from 67.49M to 38.74M, a decrease of -42.61%. That is a compound annual growth rate of -2.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 38.74M | -44.11% |
| Dec 31, 2025 | 69.30M | -34.16% |
| Dec 31, 2024 | 105.26M | -64.12% |
| Dec 29, 2023 | 293.38M | 108.23% |
| Dec 30, 2022 | 140.90M | -54.66% |
| Dec 31, 2021 | 310.77M | 130.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cleo Diagnostics | 91.70M |
| Compumedics | 76.91M |
| Micro-X | 62.44M |
| CleanSpace Holdings | 51.34M |
| Nova Eye Medical | 49.84M |
| HeraMED | 46.94M |
| CurveBeam AI | 36.03M |
| Atomo Diagnostics | 35.65M |